In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

Adults with major depressive disorder experienced statistically significant and clinically meaningful improvements with a ...

Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout ...

Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...

A record-high number of Americans say they have tried a weight-loss drug, a new national poll from Gallup found. The survey ...

For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.

Helus Pharma™ (NASDAQ: HELP) (Cboe CA: HELP), the commercial operating name of Cybin Inc., says its APPROACH Phase 3 trial of HLP003 for adjunctive treatment of major depressive disorder has surpassed ...

A serotonin receptor drug used for chronic constipation improved executive function and both short-term and long-term memory after a seven-to ten-day course. Credit: Stock A common constipation drug ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

The FDA should require negative studies of a new drug to be included in the product's labeling -- not just those studies with a beneficial finding -- to prevent physicians and consumers from being ...

When drug developers go after the same disease, clinical trial results often have a see-saw effect on the stock market. Investors inevitably view one company’s data as stronger than its rivals, and ...